May 13
|
Overview: Join Outcome Capital‘s Stanislav Glezer at BioNJ BioPartnering Conference on May 13 in Jersey City, NJ. Please reach out to Stan to hear the latest trends and happenings in the Bio world, including innovative breakthroughs, emerging market opportunities, and investment strategies. Join the Event |
The New Orleans biotech is currently raising a tiny $8 million Series A to develop its non-opioid painkiller. It keeps costs low by paying employees cash on an hourly basis—but no salaries.
Read MoreOutcome Capital Life Science Market Pulse March 2025 Click to view our LifeSciences Pulse Newsletter
DownloadWould you like to learn more about working with Outcome Capital or discuss your specific needs?